Mounting evidence has shown that acute and chronic intranasal insulin administration facilitates memory and recognition functions (Brünner et al., 2013) both in healthy individuals and patients with mild cognitive impairment of AD (Hallschmid, 2021). Here, INS is linked to Alzheimer disease.